Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
F1000Research
|
April 12, 2018
How to prevent the next Marathon Pharmaceuticals
Frank S David, Richa Dixit
F1000Research
|
November 18, 2020
Public research funding and pharmaceutical prices: do Americans pay twice for drugs?
Rena M Conti, Frank S David
Surgery
|
April 17, 2018
From innovation to market adoption in the operating room: The "CFO as customer"
Ryan D Egeland, Zachary Rapp, Frank S David
Journal of Cell Science
|
March 2, 2006
Displacement of the {beta} cytoplasmic domain recovers focal adhesion formation, cytoskeletal organization and motility in swapped integrin chimeras
Michael A Partridge, Frank S David, Eugene E Marcantonio
Plos One
|
November 6, 2020
Results of a portfolio approach to intramural research funding at an academic medical center
Anu Swaminathan, Frank S David, Lauren N Geary, et al.
Drug Discovery Today
|
November 3, 2025
Forecasting clinical trial success using anonymized external expert panels
Frank S David, R Edward Benson, Mark Gordon, et al.
BMJ Open
|
February 10, 2017
Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study
Matthieu Larochelle, Nicholas S Downing, Joseph S Ross, et al.
The Journal of Biological Chemistry
|
July 1, 2005
Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes
Heike Keilhack, Frank S David, Malcolm McGregor, et al.
The Journal of Biological Chemistry
|
December 27, 2005
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects
Maria I Kontaridis, Kenneth D Swanson, Frank S David, et al.
Anatomical Record (Hoboken, N.J. : 2007)
|
August 25, 2010
Regulation of kidney development by Shp2: an unbiased stereological analysis
Frank S David, Luise Cullen-McEwen, Xue Sue Wu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
F1000Research
|
April 12, 2018
How to prevent the next Marathon Pharmaceuticals
Frank S David, Richa Dixit
F1000Research
|
November 18, 2020
Public research funding and pharmaceutical prices: do Americans pay twice for drugs?
Rena M Conti, Frank S David
Surgery
|
April 17, 2018
From innovation to market adoption in the operating room: The "CFO as customer"
Ryan D Egeland, Zachary Rapp, Frank S David
Journal of Cell Science
|
March 2, 2006
Displacement of the {beta} cytoplasmic domain recovers focal adhesion formation, cytoskeletal organization and motility in swapped integrin chimeras
Michael A Partridge, Frank S David, Eugene E Marcantonio
Plos One
|
November 6, 2020
Results of a portfolio approach to intramural research funding at an academic medical center
Anu Swaminathan, Frank S David, Lauren N Geary, et al.
Drug Discovery Today
|
November 3, 2025
Forecasting clinical trial success using anonymized external expert panels
Frank S David, R Edward Benson, Mark Gordon, et al.
BMJ Open
|
February 10, 2017
Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study
Matthieu Larochelle, Nicholas S Downing, Joseph S Ross, et al.
The Journal of Biological Chemistry
|
July 1, 2005
Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes
Heike Keilhack, Frank S David, Malcolm McGregor, et al.
The Journal of Biological Chemistry
|
December 27, 2005
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects
Maria I Kontaridis, Kenneth D Swanson, Frank S David, et al.
Anatomical Record (Hoboken, N.J. : 2007)
|
August 25, 2010
Regulation of kidney development by Shp2: an unbiased stereological analysis
Frank S David, Luise Cullen-McEwen, Xue Sue Wu, et al.
Page
of 2